The CDC's Advisory Committee on Immunization Practices (ACIP) unanimously recommended that U.S. travelers ages 12 years and ...

The Centers for Disease Control and Prevention (CDC) has recently updated its vaccine recommendations for three critical diseases: meningococcal, respiratory syncytial virus (RSV), and chikungunya.

Health authorities are under fire for failing to issue relevant guidelines to contain Chikungunya in light of its rapid rise ...

A disabling mosquito-borne disease called chikungunya has killed six people in the French Indian Ocean island of La Reunion ...

Check all about Chikungunya, including its symptoms, treatment, prevention methods, rash details, and recovery time in this ...

Six people have died from chikungunya on the French overseas department of Réunion Island since the start of the year, health ...

The updated recommendations are pending final approval by the director of the CDC and the Department of Health and Human Services.

The Advisory Committee on Immunization Practices convened to make expanded vaccine recommendations amidst CDC leadership changes.

Valneva's chikungunya vaccine Ixchiq receives Brazil approval, enabling expanded trials and access across Latin America and ...

Valneva SE (Nasdaq: VALN; Euronext Paris: VLA), a specialty vaccine company, today announced that during its regular meeting on April 16, the U.S. Centers for Disease Control and Prevention’s (CDC) ...

VIMKUNYA was approved by the U.S. Food and Drug Administration (FDA) and the European Commission in February 2025 6,7.

Vimkunya is now available in the US for the prevention of disease caused by chikungunya virus in individuals 12 years of age ...